<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2138">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525742</url>
  </required_header>
  <id_info>
    <org_study_id>105</org_study_id>
    <nct_id>NCT04525742</nct_id>
  </id_info>
  <brief_title>COVID-19 Pandemic and Parents of Disabled Children</brief_title>
  <official_title>COVID-19 Pandemic From the Perspective of Parents of Disabled Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaziosmanpasa Taksim Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaziosmanpasa Taksim Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pandemic period could affect the disabled children's rehabilitation and follow-up negatively
      because of preventive measures and this could create adverse results on their parents.

      In this research, it is aimed to determine the positive and negative effects of pandemic on
      parents and disabled children and to provide an insight for future solutions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the effect of COVID-19 pandemic and the possible difficulties experienced by the
      parents of disabled children, a questionnaire was prepared. It takes approximately 10-15
      minutes to complete the survey. Questionnaire is loaded to qualtrics program and sent to the
      families by e-mail or social media accounts.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2020</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>One study group will be researched- only disabled children's parents, in one arm -way</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking will be done</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>A questionnaire that we created will be used to determine the difficulties experienced by disabled children's parents during Covid 19 pandemic related to their medical follow-up</measure>
    <time_frame>4 weeks</time_frame>
    <description>Difficulties related to rehabilitation facilities, other medical conditions or ortosis could increase because of Covid 19 pandemic unique conditions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Fear of COVID-19 Scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals. Score is minimum 7 pointts and maximum 35 points.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>COVID-19</condition>
  <condition>Disabilities Multiple</condition>
  <condition>Cerebral Palsy</condition>
  <condition>Muscular Dystrophies</condition>
  <arm_group>
    <arm_group_label>Parents who have a disabled child or children</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Parents having disabled child or children will be included in the research and it will be wanted to complete the survey questionary</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Difficulties lived by disabled children's parents in the period of COVID-19 pandemic</intervention_name>
    <description>It will be a cross sectional study to obtain the information on difficulties lived by disabled children's parents during recent pandemic period</description>
    <arm_group_label>Parents who have a disabled child or children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Having disabled child/children

          -  Having ability and facility to use internet

          -  Having ability to read and write

          -  Having enough cognitive capacity to answer the questionnaire

          -  To accept to participate the research

        Exclusion Criteria:

          -  Not having disabled child/children

          -  Not having ability and facility to use internet

          -  Not having ability to read and write

          -  Not having enough cognitive capacity to answer the questionnaire

          -  Not to accept to participate the research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Resa Aydin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>İstanbul University İstanbul Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Evrim Karadağ Saygı, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Özden Özyemisçi Taşkıran, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Koc University Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nalan Çapan, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>İstanbul University İstanbul Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ebru Yilmaz Yalçınkaya, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Health Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Berrin Huner, Specialist</last_name>
    <phone>+90 506 596 16 17</phone>
    <email>berrinhuner@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ebru Yilmaz Yalcinkaya, Professor</last_name>
    <phone>+90 505 451 85 73</phone>
    <email>ebru_yilmaz@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Health Science University Gaziosmanpasa Training and Research Hospital</name>
      <address>
        <city>İstanbul</city>
        <state>Gaziosmanpasa</state>
        <zip>34255</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sibel Bektas, Professor</last_name>
      <phone>+90 532 707 31 53</phone>
      <email>sibel_bektas@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Berrin Huner, Speacilist</last_name>
      <phone>+90 506 596 16 17</phone>
      <email>berrinhuner@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020 Mar 27:1-9. doi: 10.1007/s11469-020-00270-8. [Epub ahead of print]</citation>
    <PMID>32226353</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 28, 2020</study_first_submitted>
  <study_first_submitted_qc>August 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 23, 2020</last_update_submitted>
  <last_update_submitted_qc>August 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gaziosmanpasa Taksim Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Berrin Hüner</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>cerebral palsy</keyword>
  <keyword>COVID-19</keyword>
  <keyword>pandemic</keyword>
  <keyword>disability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Study protocol was established by Berrin Huner and Ebru Yilmaz Yalcınkaya Statistical analysis (Power analysis) was established by Ozden Ozyemisci Taskiran Informed consent was written by Berrin Huner</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Research is planned to bu conducted between June 15 th and July 15 th 2020. After 15 th of July in 1 week coming statistical analysis will be finished and than in 3 weeks article will be written</ipd_time_frame>
    <ipd_access_criteria>In necessary cases colleced data from the research will be shared with the local ethical committe</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

